Standard BioTools Inc (NASDAQ: LAB) closed the day trading at $2.38 down -2.86% from the previous closing price of $2.45. In other words, the price has decreased by -$0.0700 from its previous closing price. On the day, 1393830 shares were traded.
Ratios:
For a better understanding of LAB, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.87 and its Current Ratio is at 3.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, KeyBanc Capital Markets on July 12, 2023, initiated with a Overweight rating and assigned the stock a target price of $4.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 19 when Casdin Eli bought 800,000 shares for $2.29 per share. The transaction valued at 1,835,920 led to the insider holds 1,200,000 shares of the business.
Casdin Partners Master Fund, L bought 800,000 shares of LAB for $1,835,920 on May 19. The Director now owns 1,200,000 shares after completing the transaction at $2.29 per share. On May 19, another insider, Black Jeffrey G., who serves as the SVP & Chief Financial Officer of the company, bought 42,492 shares for $2.29 each. As a result, the insider paid 97,213 and bolstered with 85,984 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LAB now has a Market Capitalization of 689.75M and an Enterprise Value of 660.62M. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.56. Its current Enterprise Value per Revenue stands at 6.28 whereas that against EBITDA is -11.91.
Stock Price History:
The Beta on a monthly basis for LAB is 1.65, which has changed by 34.62% over the last 52 weeks, in comparison to a change of 28.18% over the same period for the S&P500. Over the past 52 weeks, LAB has reached a high of $3.16, while it has fallen to a 52-week low of $1.46. The 50-Day Moving Average of the stock is 2.2488, while the 200-Day Moving Average is calculated to be 2.3182.
Shares Statistics:
Over the past 3-months, LAB traded about 1.41M shares per day on average, while over the past 10 days, LAB traded about 1.29M shares per day. A total of 289.81M shares are outstanding, with a floating share count of 280.17M. Insiders hold about 3.32% of the company’s shares, while institutions hold 27.04% stake in the company. Shares short for LAB as of Jan 31, 2024 were 7.3M with a Short Ratio of 5.18, compared to 5.76M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 2.52% and a Short% of Float of 2.68%.
Earnings Estimates
Current recommendations for the stock of the company come from 1 analysts. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was $0. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$0.01 and -$0.01 for the fiscal current year, implying an average EPS of -$0.01. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
